다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
China SXT Pharmaceuticals Inc (SXTC)
China SXT Pharmaceuticals Inc (SXTC) 뉴스

SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SXTC

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/01/12	06:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/27	05:05	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/04	21:30	GlobeNewswire Inc.	China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/08/01	05:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/20	06:17	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/10	21:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	03:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	02:50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/27	19:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/01	06:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/25	07:20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/14	06:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/12/23	20:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/11/07	22:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/10/12	21:46	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/09/27	21:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/07/19	00:02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/19	01:30	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/14	05:09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/12	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/25	05:32	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/17	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/16	21:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/16	05:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/15	11:33	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/22	07:01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	20:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	01:25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	00:45	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment	NASDAQ:SXTC	China SXT Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:SXTC

1 2 3 다음 >>

Vontobel Financial Produ...

Casella Waste Systems

Nightingale Informatix Corporati

BNP Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관